Log in

NYSE:CSLTCastlight Health Stock Price, Forecast & News

+0.02 (+2.52 %)
(As of 07/3/2020 04:00 PM ET)
Today's Range
Now: $0.81
50-Day Range
MA: $0.79
52-Week Range
Now: $0.81
Volume276,123 shs
Average Volume1.25 million shs
Market Capitalization$121.77 million
P/E RatioN/A
Dividend YieldN/A
Castlight Health, Inc. provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers implementation, user and customer support, and marketplace services. It serves customers in a range of industries, including education, manufacturing, retail, technology, and government. The company was formerly known as Ventana Health Services and changed its name to Castlight Health, Inc. in April 2010. Castlight Health, Inc. was founded in 2008 and is headquartered in San Francisco, California.
Read More
Castlight Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.8Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.44 out of 5 stars

Industry, Sector and Symbol

Industry Data processing & preparation



Sales & Book Value

Annual Sales$143.31 million
Book Value$1.17 per share


Net Income$-40,000,000.00


Market Cap$121.77 million
Next Earnings Date8/4/2020 (Estimated)

Receive CSLT News and Ratings via Email

Sign-up to receive the latest news and ratings for CSLT and its competitors with MarketBeat's FREE daily newsletter.

Castlight Health (NYSE:CSLT) Frequently Asked Questions

How has Castlight Health's stock been impacted by COVID-19 (Coronavirus)?

Castlight Health's stock was trading at $0.83 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CSLT stock has decreased by 1.9% and is now trading at $0.8144. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Castlight Health?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Castlight Health in the last year. There are currently 1 sell rating and 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Castlight Health.

When is Castlight Health's next earnings date?

Castlight Health is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Castlight Health.

How were Castlight Health's earnings last quarter?

Castlight Health Inc (NYSE:CSLT) posted its earnings results on Thursday, May, 7th. The software maker reported ($0.01) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.07) by $0.06. The software maker had revenue of $39.05 million for the quarter, compared to analysts' expectations of $32.80 million. Castlight Health had a negative return on equity of 18.61% and a negative net margin of 58.42%. View Castlight Health's earnings history.

What guidance has Castlight Health issued on next quarter's earnings?

Castlight Health updated its FY 2020 After-Hours earnings guidance on Thursday, May, 7th. The company provided EPS guidance of -0.16--0.11 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $-0.13. The company issued revenue guidance of $127-135 million, compared to the consensus revenue estimate of $132.54 million.

What price target have analysts set for CSLT?

3 brokerages have issued 1 year target prices for Castlight Health's stock. Their forecasts range from $0.75 to $2.00. On average, they anticipate Castlight Health's stock price to reach $1.42 in the next twelve months. This suggests a possible upside of 74.0% from the stock's current price. View analysts' price targets for Castlight Health.

Has Castlight Health been receiving favorable news coverage?

News coverage about CSLT stock has been trending negative recently, InfoTrie Sentiment reports. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Castlight Health earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave news articles about the software maker a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about Castlight Health.

Are investors shorting Castlight Health?

Castlight Health saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 3,940,000 shares, an increase of 7.7% from the June 15th total of 3,660,000 shares. Based on an average daily volume of 756,500 shares, the short-interest ratio is presently 5.2 days. Approximately 4.3% of the shares of the stock are short sold. View Castlight Health's Current Options Chain.

Who are some of Castlight Health's key competitors?

What other stocks do shareholders of Castlight Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Castlight Health investors own include Ring Energy (REI), Ring Energy (REI), FireEye (FEYE), Gilead Sciences (GILD), NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Callon Petroleum (CPE), Corbus Pharmaceuticals (CRBP), Ford Motor (F) and Kosmos Energy (KOS).

Who are Castlight Health's key executives?

Castlight Health's management team includes the following people:
  • Dr. Bryan Eisman Roberts, Chairman (Age 52)
  • Mr. John C. Doyle, CEO & Director (Age 51)
  • Ms. Siobhan Nolan Mangini, Chief Financial Officer (Age 38)
  • Mr. M P Eric Chan, Chief Accounting Officer (Age 43)
  • Mr. Gary J. Fuges C.F.A., CFA, Head of Investor Relations

What is Castlight Health's stock symbol?

Castlight Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CSLT."

How do I buy shares of Castlight Health?

Shares of CSLT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Castlight Health's stock price today?

One share of CSLT stock can currently be purchased for approximately $0.81.

How big of a company is Castlight Health?

Castlight Health has a market capitalization of $121.77 million and generates $143.31 million in revenue each year. The software maker earns $-40,000,000.00 in net income (profit) each year or ($0.25) on an earnings per share basis. Castlight Health employs 470 workers across the globe.

What is Castlight Health's official website?

The official website for Castlight Health is www.castlighthealth.com.

How can I contact Castlight Health?

Castlight Health's mailing address is 150 SPEAR STREET SUITE 400, SAN FRANCISCO CA, 94105. The software maker can be reached via phone at 415-829-1400 or via email at [email protected]

This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.